Form 8-K CONMED CORP For: Apr 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
CONMED (CNMD) PT Raised to $95 at Needham & Company
April 25, 2019 8:26 AM EDTNeedham & Company analyst Mike Matson raised the price target on CONMED (NASDAQ: CNMD) to $95.00 (from $94.00) while maintaining a Buy rating.
The analyst commented, " CNMD's 1Q19 revenue and EPS beat consensus. Given the recent Buffalo Filter acquisition, management provided 2019 revenue guidance and also raised its... More



